In addition, a small mutation frequency of PTEN, 5% reported in other teams, was detected in our samples (3.5% of AII and 17.6% of AIII); the increasing frequency with increasing grades indicates an important role of PTEN signaling in malignant progression of a small subgroup of astrocytomas. This evidence concerns the gene PTEN and astrocytoma (excluding glioblastoma).